欧洲医护人员乙型肝炎疫苗接种政策调查:最新概览
该调查于2016年对欧盟及挪威、瑞士的职业医学代表进行电子调查并于2019年更新,了解医护人员乙肝疫苗接种政策实施情况。共收到21个国家回复,涵盖欧盟28国78%人口和60%医护人员。结果显示各国在强制接种、接种程序、接种前后血清检测及加强针政策上存在差异。
要点
- 乙肝疫苗对医疗和护理人员强制接种的国家有10个,对其他国家的这类人群多为推荐接种。
- 最常使用的接种程序为0、1、6个月(18个国家),接种后血清检测在18个国家开展。
- 乙肝疫苗接种覆盖率(5个国家)为70-95%,针刺伤报告在13个国家开展。
核心结论
- 调查结果显示参与国在实施欧盟立法方面存在差异,欧盟层面更多协商包括加强职业医学中的医学监测可能有助于优化欧洲国家政策,以进一步减少乙肝病毒传播给医护人员。
研究设计与样本
- 2016年对欧盟医学专家联盟(UEMS)职业医学部门的国家代表进行电子调查,纳入欧盟国家及挪威和瑞士,数据于2019年更新。
- 收到21个国家(其中19个欧盟成员国)的回复,代表欧盟28国78%的人口和60%的医护人员。
主要发现
- 乙肝疫苗接种对医疗和护理人员强制接种的国家有10个,对其他辅助医疗人员、医学和护理学生强制接种的国家有9个,对辅助医疗学生强制接种的国家有8个,对清洁人员强制接种的国家有7个,对技术人员强制接种的国家有5个;在其他国家中除一个外均为推荐接种。
- 接种前血清检测在7个国家开展。
- 最常使用的接种程序为0、1、6个月(18个国家),单价乙肝疫苗在14个国家使用,甲乙肝联合疫苗在11个国家使用。
- 接种后血清检测在18个国家开展,加强针在14个国家被推荐,无应答者政策在18个国家存在。
- 乙肝疫苗接种覆盖率(5个国家)为70-95%,针刺伤报告在13个国家开展,其中7个国家为全国性报告;受访者未提及欧洲范围报告。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of transmission of bloodborne pathogens, including hepatitis B virus (HBV) to healthcare workers (HCWs) is well known. In 2005 we performed a survey on HBV prevention in HCWs in the European Union (EU). An update of the 2005 survey deemed necessary as an EU Council Directive (2010/32/EU) on sharps injuries was to be implemented into national legislation by 11 May 2013 and more countries were starting universal HBV vaccination. METHODS: We performed an electronic survey in 2016, among national representatives from the Occupational Medicine section of the European Union of Medical Specialists (UEMS), to find out how policies have been put into practice in the European Union countries (plus Norway and Switzerland). The data were updated in 2019. RESULTS: Answers were received from 21 countries (among them 19 EU Member States), representing 78% of the population and 60% of HCWs in the EU-28. HBV vaccination was mandatory for medical and nursing staff in 10 countries; for other paramedical staff, medical and nursing students in 9 countries; for paramedical students in 8 countries; for cleaning staff in 7 countries; and for technical staff in 5 countries; it was recommended in all but one of other countries. Serotesting before vaccination was done in 7 countries. The vaccination schedule most often used was 0, 1, 6 months (18countries), monovalent HBV vaccine was used in 14 countries, and combined (HAV + HBV) vaccine in 11 countries. Serotesting after vaccination was done in 18 countries and boosters were recommended in 14 countries. A non-responder policy was present in 18 countries. HBV vaccination coverage (5 countries) was 70-95%. Sharps injuries were reported in 13 countries, nationwide in 7 of them; European-wide reporting was not mentioned by respondents. DISCUSSION: These results show the variation in the implementation of EU legislation in the participating countries. More consultation between actors at EU level, including enhancing medical surveillance in occupational medicine could help to optimise policies in European countries in order to further reduce HBV transmission to HCWs.
引用
- De Schryver A, Lambaerts T, Lammertyn N, et al. European survey of hepatitis B vaccination policies for healthcare workers: An updated overview. Vaccine. 2020. PMID: 32057571. doi:10.1016/j.vaccine.2020.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。